Literature DB >> 8383771

A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.

K H Kim1, P Willingmann, Z X Gong, M J Kremer, M S Chapman, I Minor, M A Oliveira, M G Rossmann, K Andries, G D Diana.   

Abstract

The three-dimensional structures of two human rhinovirus serotypes (HRV14 and HRV1A) are compared when complexed with various antiviral agents. Although these agents all bind into the same hydrophobic pocket, the exact viral-drug interactions differ. In the absence of drugs, the pocket is occupied by a fatty acid in HRV1A, but is empty in HRV14 except for two water molecules. The conformation of each drug is dependent upon the shape of the hydrophobic pocket. In HRV14 the major residues determining the shape of the binding site are Y1128, P1174 and M1224, corresponding to I1125, M1169 and I1220 in HRV1A. When there is no cofactor or a drug in the pocket, the entrance to the pocket is open. However, the entrance is closed when the pocket is occupied by a cofactor or a drug. There are relatively small conformational changes when the agents displace the natural cofactor in HRV1A. In contrast, there are much larger conformational changes on binding a drug in HRV14. These differences cause an inhibition of viral attachment in HRV14 but not in HRV1A. Binding of the drugs results in three additional interprotomer hydrogen bonds in HRV14 and one in HRV1A. These hydrogen bonds and a potential loss of flexibility upon efficient packing of the pocket may contribute to the inhibition of uncoating in both serotypes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383771     DOI: 10.1006/jmbi.1993.1137

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  26 in total

1.  An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.

Authors:  A W Dove; V R Racaniello
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.

Authors:  A T Hadfield; G D Diana; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Functional group placement in protein binding sites: a comparison of GRID and MCSS.

Authors:  R Bitetti-Putzer; D Joseph-McCarthy; J M Hogle; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

Review 4.  Picornavirus uncoating.

Authors:  M S Smyth; J H Martin
Journal:  Mol Pathol       Date:  2002-08

5.  Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus.

Authors:  D K Phelps; C B Post
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

6.  Outliers in SAR and QSAR: is unusual binding mode a possible source of outliers?

Authors:  Ki Hwan Kim
Journal:  J Comput Aided Mol Des       Date:  2007-03-03       Impact factor: 3.686

7.  Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.

Authors:  Chris Mello; Esmeralda Aguayo; Madeleine Rodriguez; Gary Lee; Robert Jordan; Tomas Cihlar; Gabriel Birkus
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 8.  Closing the door on flaviviruses: entry as a target for antiviral drug design.

Authors:  Rushika Perera; Mansoora Khaliq; Richard J Kuhn
Journal:  Antiviral Res       Date:  2008-06-11       Impact factor: 5.970

Review 9.  Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

10.  The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A.

Authors:  N Vaidehi; W A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.